Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
2,216
NCT00100282
Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2003
Completion: Jun 30, 2005
NCT00100243
Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
Phase: Phase 2
Start: May 31, 2004
Completion: Sep 30, 2005
NCT00103623
The Plenaxis® Experience Study
Phase: Phase 4
Start: Jun 30, 2004
Completion: Dec 31, 2008
NCT00100334
Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease
Phase: Phase 1/2
Start: Dec 31, 2004
Completion: Aug 31, 2005
NCT00100347
Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors
Completion: Jul 31, 2007